Access links below are restricted for registered users.



If you have registered to attend the Liver Disease 2020 course, please login to your account.

Liver disease 2020

Friday, December 04 - Saturday December 05, 2020

Plenary Sessions

Attend a keynote, short snapper, or panel discussion.

Friday, December 04Saturday, December 04

08:30 – 08:40 | Opening Remarks (Borman)

08:40 – 09:10 | Impact of COVID on Patients with Chronic Liver Disease (Tapper)

09:10 – 09:25 | Interactive Case with Q&A (Burak)

11:30 – 12:05 | Phone a Friend: Pain Points in Primary Care Panel with Q&A (Luelo, Slocombe, Borman)

08:30 – 08:35 | Opening Remarks (Borman)

08:35 – 09:05 | The Impact of Isolation: COVID-19 and Alochol Realted Liver Disease (Im)

09:05 – 09:20 | Addressing Alcohol Use Disorder in and After Hospitalization (Nguyen, Colizza)

09:20 – 09:35 | Interactive Case with Q&A (Borman)

09:45 – 10:00 | Ascites: Practical “TIPS” for Refractory Ascites Management (Gonzalez-Abraldes)

10:00 – 10:15 | Ascites: Acute Kidney Injury (the Other Organ that Matters) (Kachra)

10:15 – 10:30 | Bleeding: What the Guidelines Tell We Should Do (Burak)

10:30 – 10:45 | Bleeding: What We Actually are Doing in Calgary (Aziz Shaheen)

10:55 – 11:10 | PLP: Interactive Debrief to Plan Future A&F (Burak, Law)

11:10 – 11:40 | Toward Optimizing Practice: Caring for Hospitalized Patients with Cirrhosis (Tandon)

11:40 – 11:55 | Q&A with Interactive Case Based Discussion (Borman)

Dr. Meredith Borman completed internal medicine residency training followed by fellowships in gastroenterology and hepatology at the University of Calgary. She subsequently completed an advanced hepatology fellowship at the University of Birmingham, UK. She is a Clinical Assistant Professor in the Department of Medicine at the University of Calgary and program director for the Hepatology Fellowship Training Program. Dr. Borman has a particular interest in alcohol-related liver disease.

Dr. Elliot Tapper MD holds the Margaret Gyetko Assistant Professorship at the University of Michigan where he Directs the Michigan Cirrhosis Program. He is board certified transplant hepatologist conducting trials and outcomes research in cirrhosis with funding from NIH, PCORI, and Pharma. His work has been published in NEJM, BMJ, Hepatology, Journal of Hepatology. Follow him on Twitter @ebtapper

Dr. Kelly Burak received his BSc (Biology), MD and Internal Medicine training at the University of Saskatchewan before completing training in Gastroenterology in Calgary. He completed a Research Fellowship in Hepatology at the University of Calgary followed by a Clinical Fellowship in Hepatology and Liver Transplantation at the Mayo Clinic in Rochester, Minnesota. In 2005, Dr. Burak was awarded his MSc in Epidemiology from the University of Calgary. In 2012, Dr. Burak obtained a Graduate Certificate in Clinical Education from Flinders University in Adelaide, Australia. Dr. Burak is currently a Professor of Medicine and in 2017 he became the Associate Dean of Continuing Medical Education & Professional Development at the University of Calgary and the Co‐Lead of the Physician Learning Program. He has a passion for Medical Education and has won several teaching awards, both locally and nationally, including the Education Award from the Canadian Association for the Study of Liver Disease in 2020.

Dr. Christine Luelo graduated from the University of Alberta, Faculty of Medicine in 1997 and completed a two‐year residency in Family Medicine at the Royal Alexandra Hospital . She joined McKenzie Family Practice in 1999 where she currently works 3 days a week providing a Medical Home for approximately 1100 patients. Dr. Luelo was one of the original physicians involved in the Local Primary Care Initiative team that eventually became the PCN’s we have today. After a tenure on the South Calgary Governance Board, she accepted the position of Medical Director in June 2013 and has been actively involved in many zone collaborative efforts including design and implementation of Specialist Link phone service and Enhanced Primary Care Pathways, and physician lead for the Calgary Zone Primary Health Care Opioid Response Initiative from 2018‐2020. Dr. Luelo became physician Co‐Chair for the Zone Operations Coordinating Committee (formerly Secretariat) in 2017. Her passion for Medical Home and quality improvement has been channeled in her work with the CPSA Assessment Program Advisory Committee. Christine is happily married with two children and an Australian Labradoodle named Baxter. She is a community volunteer and loves crafts and reading.

Dr. Linda Slocombe is a family physician in Calgary doing low risk obstetrics. Administrative role with AHS as Senior Medical Director Primary Healthcare and Senior Medical Director Primary Healthcare Integration Network.

Dr. Gene Im is a transplant hepatologist at the Recanati/Miller Transplantation Institute (RMTI) and Associate Professor of Medicine, Division of Liver Diseases at the Icahn School of Medicine at Mount Sinai. My primary area of clinical and research interest is in alcohol‐associated liver disease, including screening, alcoholic hepatitis and early liver transplantation.

Dr. Kate Colizza works as a general internist in Calgary and addiction physician with the Addiction Recovery and Community Health (ARCH) team at the Peter Lougheed Hospital. She is the Assistant Medical Director of ARCH.

Dr. Gonzalez-Abraldes received his medical degree from the University of Santiago de Compostela in Spain, completed a Fellowship in Gastroenterology and Hepatology at the University of Barcelona and a postdoctoral fellowship at Yale University. He was awarded several prizes for his clinical work and research while in Europe, including the Rising Star of European Gastroenterology award from the United European Gastroenterology Federation in 2012. Dr. Abraldes is the Director of the Liver Unit. He is also a member of the division’s Research Committee. He served as the Chair of the Special Interest group in Portal hypertension of the American Society for the Study of the Liver (2017-2018), and currently serves as steering committee member for the Baveno International Cooperation for the study of Portal Hypertension. He is the co-chair of the research committee for the Canadian Association for the Study of the Liver. He is associate editor for Liver International and serves on the Editorial Board of Journal of Hepatology and Liver Transplantation. He has co-authored the American Association for the Study of the liver guidelines for the management of portal hypertension.

Dr. Rahim Kachra is a Clinical Associate Professor of Medicine; Director of Teaching Innovation and Director of the Internal Medicine Clerkship, Undergraduate Medical Education, Cumming School of Medicine, University of Calgary; MD Training Officer for Department of Medicine COVID Medicine Emergency-Pandemic Operations Command

Dr. Abdel Aziz Shaheen is an Assistant Professor, Department of Medicine and Community Health Sciences at the University of Calgary.

Sampson Law works as a Health Care Professional Project Manager for the Physician Learning Program (PLP) and has knowledge and expertise in the field of knowledge translation and healthcare quality improvement. Among the areas of expertise is the use of physician practice data to inform opportunities for improvement and education. At the PLP, Sampson uses strategies such as audit and feedback to help physicians improve the care they provide patients.

Dr. Puneeta Tandon is an Associate Professor of Medicine, Co-Director of the Cirrhosis Care Clinic and Transplant Hepatologist at the University of Alberta in Edmonton, Alberta, Canada. She completed her Internal Medicine, Hepatology and Clinical Epidemiology training at the University of Alberta with additional training at Yale University and the Hospital Clinic in Barcelona. Her clinical practice and research are focused on cirrhosis with research interests including cirrhosis related complications, malnutrition, frailty, exercise therapy, palliative care and integrative health approaches. It is her career goal to provide wholistic, interdisciplinary, patient-centered care through evidence, education, empowerment, engagement and team-work.

Dr. Anshula Ambasta is a general internist with an academic interest in health system quality improvement and patient safety. Her current work focuses on reducing over-use of laboratory tests in hospitals. She has experience with using summarized feedback on laboratory test utilization to change physician ordering behavior.

Workshop Rooms

Attend a workshop or breakout room session on Friday, December 04, 2020.

Workshop Room 1 Schedule
  • Workshop A 09:35

    MAFLD - Managing Metabolic Associated Liver Fatty Disease in the Community (Swain, Rye)

  • Workshop D 10:35

    Treating Hepatitis C in the Community Including Vulnerable Populations

Workshop Room 2 Schedule
  • Workshop B 09:35

    HBV - Making Sense of all Those Tests (Sadler, Truong)

  • Workshop E 10:35

    Liver Disease Unique to Pregnancy / HCV+HBV Including Viral Hepatitis (Vlasschaert, Coffin)

Workshop Room 3 Schedule
  • Workshop C 09:35

    #LiverTwitter - How to Stay Current Using Social Media (Tapper, Congly)

  • Workshop F 10:35

    Medical Therapy for Alcohol Use Disorder (AUD) in the Community (Ghosh, Parker)

Dr. Peter Rye is the Medical Director at the Calgary Adult Bariatric Specialty Clinic and a founding member of the Internal Medicine Wellness Centre, a comprehensive weight management program lead by Internal Medicine physicians. In 2018, he completed his subspecialty fellowship in General Internal Medicine through the University of Calgary, as well as certification as a Diplomat of the American Board of Obesity Medicine. He resides in Calgary, AB with his wife and two daughters.

Dr. Mark Swain is Professor and Head of the Division of Gastroenterology and Hepatology at the University of Calgary and holds the Cal Wenzel Family Foundation Chair in Hepatology. Dr. Swain is a clinician scientist whose basic research interests include studying the mechanisms regulating liver immunity and liver disease-associated symptoms, including fatigue. His clinical interests focus mainly on fatty liver disease, autoimmune liver disease and viral hepatitis. He is the President Elect for the Canadian Association for the Study of the Liver (CASL) and was appointed as a Fellow of the American Association for the Study of Liver Diseases in 2014. He is a founding member and current steering committee member of the Canadian Non-alcoholic Fatty Liver Disease Network and the Canadian Network for Autoimmune Liver Disease. For his career accomplishments and significant contributions to research and patient care he was inducted as a Fellow of the Canadian Academy of Health Sciences in 2019.

Dr. Gisela Macphail graduated from University of Calgary in 1988, did her rotating internship in Victoria BC, then internal medicine in Calgary, followed by an Infectious Diseases Fellowship. She then did a Master’s of Public Health at the Harvard School of Public Health. Twenty‐one years ago, she was approached by the medical director of CUPS, an inner city clinic, to run an on‐site hepatitis C clinic for people struggling with poverty, addictions and/or mental health issues. This was before the general medical community accepted that this could and should be done. She has been blessed to work with excellent nurses through the years and has seen that serving this population is extremely rewarding. It has been an amazing two decades – seeing the revolutionary changes from interferon and ribavirin to pegylated interferon and on to the direct acting antivirals. She loves seeing how patients respond to the simple kindnesses the rest of us take for granted and witnessing lives changed through the multidisciplinary integrative care offered at CUPS.

Ian Potapoff is a harm reduction and recovery advocate in Calgary, Alberta. He has lived experience with Hepatitis C and has undergone treatment. Ian will be sharing one part of his story to help care providers understand the perspective of a client receiving diagnosis and treatment.

Dr. Matthew Sadler received his MD with Special Training in Research from the University of Alberta (2009). He completed his internal medicine (2012) and gastroenterology (2014) residency training programs at the University of Calgary. He was awarded a Vertex / Canadian Association for the Study of the Liver Clinical Hepatology Fellowship to complete advanced hepatology training at King’s College Hospital in London, England (2015) and University of Calgary (2016). He worked at the University of Alberta Hospital as a Transplant Hepatologist prior to joining the Calgary Liver Unit in 2018. Dr. Sadler has a clinical interest in transplant hepatology, viral hepatitis, hepatocellular carcinoma and improving access to care and outcomes in patients with chronic liver disease.

Dr. Barney Truong completed his medical degree at the University of Alberta, Family Medicine Residency at the University of Calgary. He is currently working at a community-based practice as a Family Physician in Southeast Calgary. He serves a large immigrant patient population, mostly from Southeast Asia. He is also a physician board member for the Mosaic Primary Care Network.

Dr. Meghan Vlasschaert works in General Internal Medicine for Alberta Health Services at Foothills Medical Centre and Peter Lougheed Centre; she is also a Clinical Lecturer for Internal Medicine and Obstetrics & Gynecology at the Cumming School of Medicine, University of Calgary.

Dr. Carla Coffin is an Associate Professor of Medicine, Director of the Liver Unit, Joint Appointment, Department of Microbiology & Infectious Diseases. Dr. Coffin received her MSc from Memorial University of Newfoundland and completed a residency in Internal Medicine and Gastroenterology at the University of Calgary. Dr. Coffin’s clinical and translational research interests are in chronic hepatitis B infection, especially in unique patient populations (i.e., pregnancy, non-alcoholic fatty liver disease, viral hepatitis and HIV co-infection, liver transplantation, immunosuppression). Dr. Coffin’s research encompasses bench laboratory work on hepatitis B virus molecular virology, immunology, clinical outcomes/epidemiological studies as well as clinical trials on chronic hepatitis B infection.

Dr. Elliot Tapper holds the Margaret Gyetko Assistant Professorship at the University of Michigan where he Directs the Michigan Cirrhosis Program. He is board certified transplant hepatologist conducting trials and outcomes research in cirrhosis with funding from NIH, PCORI, and Pharma. His work has been published in NEJM, BMJ, Hepatology, Journal of Hepatology. Follow him on Twitter @ebtapper

Dr. Stephen Congly obtained his MD from the University of Alberta in 2006. He completed internal medicine and gastroenterology training at the University of Calgary and subsequently fellowships in Hepatology at the University of Calgary and in Transplant Hepatology at Mayo Clinic, Rochester MN. Dr. Congly is a Fellow of the Royal College of Physicians and Surgeons of Canada and board certified by the American Board of Internal Medicine in Internal Medicine, Gastroenterology and Transplant Hepatology. He has a Master’s of Science in Health Economics, Policy and Management from the London School of Economics and is a Fellow of the American College of Physicians.

Dr. Monty Ghosh is an Internist and Addiction Specialist who works at the University of Alberta Hospital in Edmonton as an Internist as well as the Sheldon Chumir and Rockyview Hospitals doing Addiction Medicine in Calgary. He works with multiple community based not for profit organizations to provide support for marginalized populations including The Alex and The Calgary Drop‐In Centre. He is an assistant clinical professor at both The University of Alberta and the University of Calgary, and is heavily involved with provincial policy building in Alberta, as well as with research and is the recipient or co‐recipient of grants from Alberta Innovates, Alberta Health, and the Canadian Institute of Health Research.

Cassidy Parker has worked as an Addictions Counsellor for 13 years. For the past two years, she has supervised the Day Program and Outpatient Counselling Team at Adult Addictions Services Calgary (AASC). Cassidy has a Bachelor of Sciences Degree with Specialization in Psychology from the University of Alberta. She is currently finishing a Social Work Degree from the University of Victoria. Cassidy has worked extensively with patients diagnosed with liver cirrhosis as they are typically required to complete the Day Program at AASC as part of their involvement with the Southern Alberta Transplant Program.